Andrew Grace
Founder/CEO, TCEB Limited
TCEB provide means to obtain frozen tissue enabling disease characterisation that will guide precision therapy. Targeted Cryo-Enabled Biopsy (TCEB) enables clinical access. Initial applications will be in cardiology then oncology.
Events Andrew Grace has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026